In the BioHarmony Drug Report Database

"Preview" Icon

Amphotericin b

Abelcet, Ambisome, Amphotec, Fungizone (amphotericin b) is a small molecule pharmaceutical. Amphotericin b was first approved as Abelcet on 1982-01-01. It is used to treat aids-related opportunistic infections, aspergillosis, blastomycosis, chronic mucocutaneous candidiasis, and coccidioidomycosis amongst others in the USA.

 

Trade Name

 

Abelcet, Ambisome, Amphotec, Fungizone
 

Common Name

 

amphotericin b
 

ChEMBL ID

 

CHEMBL267345
 

Indication

 

aids-related opportunistic infections, aspergillosis, blastomycosis, chronic mucocutaneous candidiasis, coccidioidomycosis, cryptococcal meningitis, cutaneous candidiasis, cystitis, fungemia, histoplasmosis, mycoses, neutropenia, paracoccidioidomycosis, peritonitis, sporotrichosis, urinary tract infections, visceral leishmaniasis, zygomycosis
 

Drug Class

 

Image (chem structure or protein)

Amphotericin b structure rendering